Leila Alem
1 
, Mohammad Ali Esmaeil pour
2 , Oscar Felipe Borja Montes
3 , Azadeh Khayyat
4 , Parisa Kaviani
5* , Mehrnoosh Ebadi
6 1 Research Associate, Nickan Research Institute, Isfahan, Iran
2 Resident Physician, Internal Medicine Department of UNC Health Blue Ridge, Morganton, NC, USA
3 Resident Physician, Internal Medicine Department, University of New Mexico, School of Medicine, Albuquerque, NM, USA
4 Resident Physician, Pathology Department of Medical College of Wisconsin, Milwaukee, WI, USA
5 Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
6 Research Associate, Anatomy and Cell Biology Department, University of Iowa Healthcare, Iowa City, IA, USA
Implication for health policy/practice/research/medical education:
Oncohypertension addressed the connection between cancer and hypertension. High blood pressure is a common comorbidity in cancer patients. Similarly, several anti-cancer drugs can exacerbate the new onset of hypertension or aggravate pre-existing high blood pressure by several mechanisms. Therefore, the connection between hypertension and cardiovascular mortality, morbidity, and renal function requires further investigation. The oncohypertension serve as a new entity among oncologist, nephrologist, and cardiologist.
Please cite this paper as: ALem L, Esmaeil pour MA, Borja Montes OF, Khayyat A, Kaviani P, Ebadi M. Oncohypertension; treatment of high blood pressure in cancer patients. J Nephropathol. 2023;12(4):e21513. DOI: 10.34172/jnp.2023.21513.